Atlas Trials

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Clinical trial NCT03179605 · TERMINATED

Trial details

NCT number
NCT03179605
Sponsor
Primus Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Psoriasis
Start date
2017-05-02
Primary completion
2019-06-03
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.